Christopher Breder

Person

Bethesda, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
- Patent number 12,121,523
- Issue date Oct 22, 2024
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment of CNS disorders
- Patent number 11,911,368
- Issue date Feb 27, 2024
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment of aggression
- Patent number 11,638,708
- Issue date May 2, 2023
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
- Patent number 11,458,143
- Issue date Oct 4, 2022
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
- Patent number 11,324,753
- Issue date May 10, 2022
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 11,135,171
- Issue date Oct 5, 2021
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,537,526
- Issue date Jan 21, 2020
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,500,160
- Issue date Dec 10, 2019
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,206,881
- Issue date Feb 19, 2019
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment of aggression
- Patent number 10,201,547
- Issue date Feb 12, 2019
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,130,586
- Issue date Nov 20, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,076,497
- Issue date Sep 18, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,071,057
- Issue date Sep 11, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,064,825
- Issue date Sep 4, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 10,064,824
- Issue date Sep 4, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment of aggression
- Patent number 10,058,556
- Issue date Aug 28, 2018
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,968,559
- Issue date May 15, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Opioid agonist formulations with releasable and sequestered antagonist
- Patent number 9,949,930
- Issue date Apr 24, 2018
- Purdue Pharma L.P.
- Christopher Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,877,924
- Issue date Jan 30, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,872,836
- Issue date Jan 23, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,867,784
- Issue date Jan 16, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,867,783
- Issue date Jan 16, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,861,583
- Issue date Jan 9, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,861,582
- Issue date Jan 9, 2018
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing opioid agonist, opioid antago...
- Patent number 9,808,453
- Issue date Nov 7, 2017
- Purdue Pharma L.P.
- Benjamin Oshlack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment of aggression
- Patent number 9,801,887
- Issue date Oct 31, 2017
- Supernus Pharmaceuticals, Inc.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,757,341
- Issue date Sep 12, 2017
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,693,961
- Issue date Jul 4, 2017
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing opioid agonist, opioid antago...
- Patent number 9,561,225
- Issue date Feb 7, 2017
- Purdue Pharma L.P.
- Benjamin Oshlack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation containing gelling agent
- Patent number 9,522,115
- Issue date Dec 20, 2016
- Purdue Pharma L.P.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF TREATMENT OF CNS DISORDERS
- Publication number 20230355589
- Publication date Nov 9, 2023
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
- Publication number 20230102784
- Publication date Mar 30, 2023
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
- Publication number 20220233548
- Publication date Jul 28, 2022
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20200138720
- Publication date May 7, 2020
- Purdue Pharma LP
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF CNS DISORDERS
- Publication number 20200069653
- Publication date Mar 5, 2020
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF AGGRESSION
- Publication number 20200022986
- Publication date Jan 23, 2020
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20190117580
- Publication date Apr 25, 2019
- Purdue Pharma LP
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20190110996
- Publication date Apr 18, 2019
- Purdue Pharma LP
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20190070119
- Publication date Mar 7, 2019
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20190015341
- Publication date Jan 17, 2019
- Purdue Pharma LP
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF AGGRESSION
- Publication number 20180325912
- Publication date Nov 15, 2018
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20180147151
- Publication date May 31, 2018
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20180125788
- Publication date May 10, 2018
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF AGGRESSION
- Publication number 20180055853
- Publication date Mar 1, 2018
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20180055771
- Publication date Mar 1, 2018
- Purdue Pharma LP
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20180021262
- Publication date Jan 25, 2018
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGO...
- Publication number 20180021330
- Publication date Jan 25, 2018
- Purdue Pharma LP
- Benjamin Oshlack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20170296533
- Publication date Oct 19, 2017
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
- Publication number 20170266195
- Publication date Sep 21, 2017
- SUPERNUS PHARMACEUTICALS, INC.
- Christopher D. Breder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGO...
- Publication number 20170157115
- Publication date Jun 8, 2017
- Purdue Pharma LP
- Benjamin Oshlack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20170112765
- Publication date Apr 27, 2017
- Purdue Pharma LP
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20170065524
- Publication date Mar 9, 2017
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20170065525
- Publication date Mar 9, 2017
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20170020864
- Publication date Jan 26, 2017
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20170020863
- Publication date Jan 26, 2017
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20160151291
- Publication date Jun 2, 2016
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20160151356
- Publication date Jun 2, 2016
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20160151297
- Publication date Jun 2, 2016
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20160151358
- Publication date Jun 2, 2016
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulation Containing Gelling Agent
- Publication number 20160151360
- Publication date Jun 2, 2016
- The P.F. Laboratories, Inc.
- Curtis Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christopher Breder

Person

Patents Grantslast 30 patents

Method of treatment of attention deficit/hyperactivity disorder (ADHD)

Method of treatment of CNS disorders

Method of treatment of aggression

Method of treatment of attention deficit/hyperactivity disorder (ADHD)

Method of treatment of attention deficit/hyperactivity disorder (ADHD)

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Method of treatment of aggression

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Method of treatment of aggression

Pharmaceutical formulation containing gelling agent

Opioid agonist formulations with releasable and sequestered antagonist

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing opioid agonist, opioid antago...

Method of treatment of aggression

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing gelling agent

Pharmaceutical formulation containing opioid agonist, opioid antago...

Pharmaceutical formulation containing gelling agent

Patents Applicationslast 30 patents

METHOD OF TREATMENT OF CNS DISORDERS

METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)

METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)

Pharmaceutical Formulation Containing Gelling Agent

METHOD OF TREATMENT OF CNS DISORDERS

METHOD OF TREATMENT OF AGGRESSION

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

METHOD OF TREATMENT OF AGGRESSION

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

METHOD OF TREATMENT OF AGGRESSION

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGO...

Pharmaceutical Formulation Containing Gelling Agent

METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)

PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGO...

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent

Pharmaceutical Formulation Containing Gelling Agent